Systemic sclerosis (SSc) is an autoimmune disease, characterized by fibrosis of the skin and other organs, vascular impairment and deficient immune responses. Mucosal-associated invariant T cells (MAIT) have been involved in various inflammatory and autoimmune diseases. The aims of this study were to determine the frequencies of MAIT cells in the blood of patients with systemic sclerosis (SSc) and to compare their distribution in different types of SSc. Blood samples from patients with SSc and healthy controls were examined by flow cytometer to analyse the frequencies of MAIT and cd T cells. We demonstrate that in SSc the frequencies and absolute numbers of MAIT and cd T cells are significantly reduced in comparison with healthy controls. MAIT and cd T cells did not correlate with C-reactive protein, BNP, pulmonary involvement or median skin fibrosis scale, steroid amount or disease duration. In addition, MAIT and cd T cells decrease did not stratify with gender, interstitial lung disease or active digital ulcers. Functional studies are necessary to determine the signification of MAIT cells decrease in systemic sclerosis.
Introduction
Systemic sclerosis (SSc) is an autoimmune disease, characterized by fibrosis of the skin and other organs, vascular impairment and deficient immune responses [1] . The latter has been shown on various studies as decreased regulatory T cells, impaired T cytotoxic lymphocytes and, more recently, B cell activation [2] .
Mucosal-associated invariant T (MAIT) cells are innatelike lymphocytes, accounting for 10% of peripheral blood T cells, and mostly located in mucosal tissues and the liver [3, 4] . They are characterized by invariant TCR repertoire, high expression of CD161, cytotoxic activity and production of various pro-inflammatory cytokines, such as tissue necrosis factor-a (TNF-a), interleukin-17 (IL-17) and interferon-c (IFN-c). MAIT cells have been recently analysed in various autoimmune diseases, and decreased levels in peripheral blood have been shown in rheumatoid arthritis, ankylosing spondylarthritis, inflammatory bowel disease and SLE [5] [6] [7] . In arthritis, the frequency of MAIT cells is increased in inflamed joint and decreased in blood levels [5] . In contrast to MAIT cell deficiency in various autoimmune diseases, murine collagen-induced arthritis MR1 À/À mice, which lack MAIT cells, have reduced severity of collagen antibody-induced arthritis [8] . In ulcerative colitis, circulating levels of MAIT cells were significantly reduced, but their abundance in inflamed mucosa correlated with colitis clinical and endoscopic activity [7] . The role of MAIT cells in autoimmune diseases remains to be determined, but their capacity to secrete proinflammatory cytokines could be one factor [8] .
The aims of this study were to determine the frequencies of MAIT cells in the blood of patients with SSc and to compare their distribution and organ involvement in different types of SSc. We demonstrate that in SSc the frequencies of MAIT cells are significantly reduced, whereas no particular association was noted with the SSc phenotype and organ impairment. We also show a significant decrease in blood cd T cell levels in patients with SSc in comparison with healthy controls.
Patients and methods
Twenty-seven patients with SSc and 15 healthy controls were included in this study. SSc diagnosis was confirmed using international diagnostic criteria (ACR 2013), without other associated autoimmune disease. All except 12 patients had no specific treatment at the time of cell analysis. Among the 12 treated patients, six had low-dose steroids (prednisone equivalent less than 7.5 mg/day) and three hydroxychloroquine. Healthy controls have been provided by 'Etablissement francais de Sang, Saint Antoine' and have no chronic disease, viral infection and no treatments. For all patients, the following data were analysed as follows: (1) age, gender, date of first Raynaud's phenomena, type of SSc (diffuse dSSc or limited lSSc), active digital ulcers, organ involvements, modified Rodnan skin score (mRss), muscle weakness, arthritis; (2) C-reactive protein, brain natriuretic protein (BNP), creatinine and lymphocyte levels, the presence and type of antinuclear antibodies; (3) the presence of arterial hypertension (PAPs > 30 mm Hg) on heart echography and if elevated cardiac catheterization confirmation, lung fibrosis on high-resolution CT, forced vital capacity (FVC), diffusing lung capacity for carbon monoxide single breath (DLCO) (% of predicted values) ( Table 1 ). Biological samples. Venous blood samples were collected in EDTA vacutainers (BD Biosciences, Le Pont de Claix, France), and peripheral blood mononuclear cells (PBMCs) were isolated by a standard gradient centrifugation procedure on a lymphocyte separation medium [Lymphosep separation media (Dutscher, Issy-les-Moulineaux, France)], frozen in Cryostore solution (Sigma-Aldrich, Saint-Quentin Fallavier, France) and conserved in liquid nitrogen until use.
Phenotype analysis by cytometry. After thawing, PBMCs were stained with the following fluorochrome-conjugated antibodies: FITC-CD45, APC-Alexa750-CD3, PECy5.5-TCR cd, Pacific Blue-CD4, APC-Alexa700-CD8 (all from Beckman Coulter, Villepinte, France), BV510-CD56 (BD Biosciences), APC-TCRVa7.2 and PE-Cy7-CD161 (Sony Biotechnology, Weybridge, UK). Cells were analysed on a Gallios flow cytometer (Beckman Coulter). Data were analysed using KALUZA 5.1 software (Beckman Coulter).
Statistical analysis. Data are expressed as means AE SD or medians with ranges and numbers with their frequencies.
Qualitative values were compared by the parametric chisquare test or Fischer test according to distribution and continuous quantitative variables by the Student's t-test or Mann-Whitney tests. The Pearson test was used to determine the correlation between variables. The analyses were carried out using GRAPHPAD PRISM 5.0 (GraphPad Software, San Diego, CA, USA), and a P < 0.05 value was considered as significant.
Results

MAIT cells are deficient in patients with systemic sclerosis
Patients' characteristics are shown in Table 1 . Their median age was 60 (18-80) years, 81% were female and 26% had diffuse cutaneous SSc (dSSc). Total CD3 + , CD4 + , CD8 + , double-negative CD3 + , CD56 + NK cells levels were similar in patients with SSc and controls (data not shown). The gating strategy to identify MAIT cells is shown in Fig. 1 . MAIT cells were defined as TCRVa7.2+, CD161
high among CD3 + T cells (Fig. 1A) . MAIT cell percentages among CD3 + T cells and absolute numbers were significantly reduced in patients with SSc as compared to controls: 0.9 AE 1.2% versus 3.3 AE 2.8%; P = 0.02, and 12 AE 17 cells/ll versus 40 AE 36 cells/ll; P = 0.03, respectively, whereas the number of CD3 + T cells was similar (Fig. 1B-C) . Similar significant differences were found for cd T cells between patients with SSc and controls: 2.1 AE 2% versus 4.1 AE 3.3%; P = 0.001, and 27 AE 22 cells/ll versus 63 AE 72 cells/ll; P = 0.04, respectively ( Fig. 1D-E) . We observed that MAIT cell frequency (among total CD3 + lymphocytes) and absolute numbers in patients with SSc did not correlate with Creactive protein, BNP, DLCO/VA or CPT, mRss, steroid amount or disease duration. In addition, MAIT cell decrease did not stratify with gender, interstitial lung disease or active digital ulcers. The cd T cell frequency and absolute numbers did not correlate with C-reactive protein, BNP, DLCO/VA or CPT, mRss, steroid amount or disease duration.
Comparison of MAIT cells in patients with lSSc and dSSc
Among the 27 patients with SSc, there were seven with dSSc and 20 with lSSc. Among patients' general characteristics, only the median mRss was significantly more extensive in patients with dSSc, as expected (Table 2) . MAIT cell levels were similar in patients with dSSc and lSSc, as were total CD3 + , CD4 + , CD8 + , double-negative CD3 + , CD56 + CD16 À cells levels (data not shown).
Discussion
In this study, we show for the first time that MAIT and cd T cell levels are reduced in patients with SSc in comparison [5, 6, [9] [10] [11] . In ulcerative colitis and rheumatoid arthritis, a decrease in blood circulating MAIT cells was associated with their enrichment in synovitis and inflamed mucosa, arguing for the implication of MAIT cells as pro-inflammatory trigger on local sites. In this model, the decrease in blood MAIT cells seems to be explained by the redistribution to peripheral sites. Despite reduced MAIT cell blood levels, an activated phenotype was shown in patients with vasculitis, with increased CD69 expression and IFN-c production [9] . The decrease in collagen antibody-induced arthritis severity in the absence of MAIT cells also argues for a functional implication of these cells as pro-inflammatory cells. On the other hand, in some diseases, the reduced circulating MAIT cell levels could raise the question of a possible negative regulation of pro-inflammatory cells in the context of persistent inflammation, with increased apoptosis or impaired development. MAIT cells have been demonstrated to be functionally impaired in Sjogren's syndrome, with a less activated profile and reduced capacity to secrete TNF-a and IFN-c [12] . Another report on ulcerative colitis showed decreased blood and mucosal levels of MAIT cells, with enhanced pro-apoptotic features. The decrease in MAIT cells with age has been previously reported in healthy controls and other autoimmune diseases [9] . Although we have not studied the MAIT cell activation phenotype and the capacity to secrete inflammatory cytokines, we can speculate that activated MAIT profile and redistribution to peripheral sites such as the digestive tract, skin and lung could constitute an additional mechanism of persistent pro-inflammatory profile in progressive SSc disease.
We did not find any correlation of MAIT cells with inflammatory markers, such as C-reactive protein, similarly to previous reports in systemic vasculitis [9] . The observed MAIT cell decrease persisted during the disease evolution, and no correlation was found with the SSc duration. Although no correlation was found between blood MAIT cells and lung disease severity and progression, future studies should evaluate a possible local MAIT cell enrichment in the lungs of patients with SSc. The role of MAIT cells in autoimmune disease, either as primary phenomena implicated in proinflammatory signal or induced amplification in response to deregulated cytokine context, still remains to be determined [13] .
Another relevant question is whether the MAIT cell decrease in autoimmune diseases is the consequence of immunosuppressive drugs, in particular steroids [13] . Despite the intake of low-dose prednisone by some patients in our study, the levels of conventional T cells remained similar to controls and argue against a decrease in MAIT and cd T cells in patients with SSc induced by immunosuppression. Further studies are necessary to determine the functional profile of MAIT cells in SSc and their implication for the involvement of peripheral sites such as lungs and skin. 
